Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP965344.RApgOJ7A6o7x8CA4xpLiv44p0V-FnEZKvQty6Ez6r9UYI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP965344.RApgOJ7A6o7x8CA4xpLiv44p0V-FnEZKvQty6Ez6r9UYI130_assertion type Assertion NP965344.RApgOJ7A6o7x8CA4xpLiv44p0V-FnEZKvQty6Ez6r9UYI130_head.
- NP965344.RApgOJ7A6o7x8CA4xpLiv44p0V-FnEZKvQty6Ez6r9UYI130_assertion description "[GIP response to SFA ingestion is prolonged in nondiabetic patients with NASH and is correlated with liver disease, an unfavorable dynamic adipokine profile, and beta cell dysfunction, which provides a rationale for GIP antagonism in these subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965344.RApgOJ7A6o7x8CA4xpLiv44p0V-FnEZKvQty6Ez6r9UYI130_provenance.
- NP965344.RApgOJ7A6o7x8CA4xpLiv44p0V-FnEZKvQty6Ez6r9UYI130_assertion evidence source_evidence_literature NP965344.RApgOJ7A6o7x8CA4xpLiv44p0V-FnEZKvQty6Ez6r9UYI130_provenance.
- NP965344.RApgOJ7A6o7x8CA4xpLiv44p0V-FnEZKvQty6Ez6r9UYI130_assertion SIO_000772 19141695 NP965344.RApgOJ7A6o7x8CA4xpLiv44p0V-FnEZKvQty6Ez6r9UYI130_provenance.
- NP965344.RApgOJ7A6o7x8CA4xpLiv44p0V-FnEZKvQty6Ez6r9UYI130_assertion wasDerivedFrom befree-20150227 NP965344.RApgOJ7A6o7x8CA4xpLiv44p0V-FnEZKvQty6Ez6r9UYI130_provenance.
- NP965344.RApgOJ7A6o7x8CA4xpLiv44p0V-FnEZKvQty6Ez6r9UYI130_assertion wasGeneratedBy ECO_0000203 NP965344.RApgOJ7A6o7x8CA4xpLiv44p0V-FnEZKvQty6Ez6r9UYI130_provenance.